PCN23 ADDING RITUXIMAB TO STANDARD CHEMOTHERAPY IS COST NEUTRAL AND CLINICALLY SUPERIOR IN ADVANCED STAGE NON-HODGKIN'S LYMPHOMA (NHL)

✍ Scribed by K Hieke; M Herold

• Book ID: 119594349
• Publisher: John Wiley and Sons
• Year: 2006
• Tongue: English
• Weight: 89 KB
• Volume: 9
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/s1098-3015(10)63453-5